GILEAD SCIENCES SL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $95.8B
Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 192
- Registration Number
- NCT00445146
Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2012-01-27
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 54
- Registration Number
- NCT00424021
Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
- Conditions
- Pulmonary Arterial Hypertension
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2009-04-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 186
- Registration Number
- NCT00423748
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
- Conditions
- Pulmonary Arterial Hypertension
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2009-04-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 186
- Registration Number
- NCT00423202
Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2013-06-17
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 36
- Registration Number
- NCT00423592
Phase I/II Study of hLL1 in Multiple Myeloma
- Conditions
- Myeloma, Plasma-CellPLASMACYTOMAMultiple Myeloma
- Interventions
- Biological: milatuzumab
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 25
- Registration Number
- NCT00421525
- Locations
- 🇺🇸
Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
🇺🇸Center for Cancer Care, Goshen, Indiana, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
Safety Study of NHL With 90Y-hLL2 IgG
- Conditions
- B-cell NHLNon-Hodgkins LymphomaNHL
- Interventions
- Biological: 90Y-hLL2
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 59
- Registration Number
- NCT00421395
- Locations
- 🇩🇪
Universitatsklinikum University of Saarland, Homburg/Saar, Germany
🇫🇷Research Unit 463 INSERM, Nantes, Cedex, France
🇫🇷Service des Maladies du Sang, Lille, France
Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
- Conditions
- Febrile Neutropenia
- Interventions
- Drug: Liposomal amphotericin B (AmBisome®)
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2011-03-11
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT00421187
- Locations
- 🇬🇷
Gilead Sciences, Athens, Greece
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 661
- Registration Number
- NCT00389675
- Locations
- 🇺🇸
Arkansas Primary Care Clinic, PA, Little Rock, Arkansas, United States
🇺🇸Medical Investigators, Inc., Little Rock, Arkansas, United States
🇺🇸St John's Center for Clinical Research, Jacksonville, Florida, United States
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 849
- Registration Number
- NCT00389779
- Locations
- 🇺🇸
NEA Clinic, Jonesboro, Arkansas, United States
🇺🇸Cardiovascular Research Inst. of Dallas, Dallas, Texas, United States
🇺🇸Central Cardiology Medical Clinic, Bakersfield, California, United States